Lv61
3170 积分 2023-02-27 加入
[Interpretation on the report of global cancer statistics 2022]
1个月前
已完结
Intraperitoneal Paclitaxel with Systemic S-1 Plus Oxaliplatin for Advanced or Recurrent Gastric Cancer with Peritoneal Metastasis: A single-arm, multicenter phase II clinical trial
2个月前
已完结
Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
2个月前
已完结
皖公网安备34019202002308
